Pharma firms Zenara, BDR get DCGI nod for Favipiravir versions

The two companies said the Drugs Controller General of India has given them approval to manufacture Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of COVID-19

from The Hindu - Business https://ift.tt/3ien0bd
via IFTTT